Hombach Robert J. insider trades
Hombach Robert J. has filed 18 Form 4s with the SEC that we hold, for Embecta Corp. (EMBC) (Director), Biomarin Pharmaceutical INC (BMRN) (Director), APTX (Director) and Henry Schein INC (HSIC) (Director), among 6 companies in all. Across all of them we count 4 purchases worth $651.7K and 0 sales worth $0 reported on Form 4. In the last 12 months: 2 purchases ($459.7K) and 0 sales ($0). The largest single trade was a purchase of 13,000 shares of Seaport Therapeutics, Inc. worth $235.8K, dated 2026-06-22. The first filing on our record is dated 2021-07-07 and the latest 2026-08-13.
Embecta Corp. (EMBC)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-08-12 | P, purchase reported on Form 4 | 45,000 | $223.8K | 2026-08-13 |
Biomarin Pharmaceutical INC (BMRN)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
APTX
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-11-11 | P, purchase reported on Form 4 | 5,400 | $13.0K | 2021-11-16 |
| 2021-11-12 | P, purchase reported on Form 4 | 74,600 | $179.0K | 2021-11-16 |
Henry Schein INC (HSIC)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Seaport Therapeutics, Inc. (SPTX)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-06-22 | P, purchase reported on Form 4 | 13,000 | $235.8K | 2026-06-24 |
Carmax INC (KMX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1496182) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms